Safety and Clinical Activity of Itolizumab in aGVHD

NCT05823675 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Acute Graft Versus Host Disease

Interventions

DRUG: Itolizumab
DRUG: Methylprednisolone

Sponsor

Biotech Pharmaceutical Co., Ltd.